STAT+: Pfizer moves forward with its hopes for a monthly ...
Pfizer reported that its newly acquired weight loss drug showed promise as a monthly treatment, though the field is growing increasingly ...
What’s Happening
Real talk: Pfizer reported that its newly acquired weight loss drug showed promise as a monthly treatment, though the field is growing increasingly competitive.
Health Health Fearing ICE crackdown, immigrants nationally are avoiding treatment, sometimes with dire consequences By Daniel Payne Pharmalot Pharmalot STAT Plus: As U. Officials move to reduce animal testing in research, focus may shift to restrictions on imports By Ed Silverman Health tech Health tech STAT Plus: New data shows how HHS is implementing Trump AI mandates By Brittany Trang Health tech Health tech STAT Plus: AI could soon renew prescriptions without clinician help. (wild, right?)
Should the FDA make sure its safe?
Why This Matters
By Mario Aguilar First Opinion First Opinion Plain language abstracts can help reduce misuse of science By Kirstin R.
Medical professionals are taking note of this development.
The Bottom Line
This story is still developing, and we’ll keep you updated as more info drops.
Thoughts? Drop them below.
Daily briefing
Get the next useful briefing
If this story was worth your time, the next one should be too. Get the daily briefing in one clean email.
Reader reaction
